Most Cited & Viewed

Most Cited & Viewed Papers

Citations Article
 
Does Cannabidiol (CBD) in Food Supplements Pose a Serious Health Risk? Consequences of the European Food Safety Authority (EFSA) Clock Stop Regarding Novel Food Authorisation
by Dirk W. Lachenmeier, Constanze Sproll and Stephan G. Walch
 
Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression
by Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, Helena D. Aicher, Xaver Funk, Michiel van Elk, Marianna Graziosi, Prisca R. Bauer, Milan Scheidegger and David B. Yaden
 
Transpersonal Ecodelia: Surveying Psychedelically Induced Biophilia
by Alexander Irvine, David Luke, Freya Harrild, Sam Gandy and Rosalind Watts
 
New Psychoactive Substances: Health and Legal Challenges
by Inês C. Santos, Daniela Maia, Ricardo Jorge Dinis-Oliveira and Daniel José Barbosa
 
A Multi-Level Analysis of Biological, Social, and Psychological Determinants of Substance Use Disorder and Co-Occurring Mental Health Outcomes
by Cecilia Ilaria Belfiore, Valeria Galofaro, Deborah Cotroneo, Alessia Lopis, Isabella Tringali, Valeria Denaro and Mirko Casu
 
Insights, Life Changes and Lifestyle Changes Reported by Individuals Consuming Ayahuasca in Naturalistic Settings: Nature, Frequency and Associations with Mental Health and Wellbeing
by Daniel Perkins, Emerita Opaleye, Jose Carlos Bouso, Luis Fernando Tófoli, Jerome Sarris, Violeta Schubert, Simon Ruffell and Hana Simonova
 
Factors Associated with Changes in E-Cigarette Use and Tobacco Smoking by Adolescents and Young People in Nigeria during the COVID-19 Pandemic
by Morenike Oluwatoyin Folayan, Omolola T. Alade, Heba Sabbagh, Afolabi Oyapero, Yewande I. Adeyemo, Bamidele Olubukola Popoola, Abiola A. Adeniyi, Jocelyn Eigbobo, Maryam Quritum, Chioma Nzomiwu, Nneka Maureen Chukwumah and Maha El Tantawi
 
Tripping to Cope: Coping Strategies and Use of Hallucinogens during the COVID-19 Pandemic in Three Cultural Contexts
by Genís Ona, Dóra Révész, Maja Kohek, Giordano N. Rossi, Juliana M. Rocha, Rafael G. dos Santos, Jaime E. C. Hallak, Miguel Ángel Alcázar-Córcoles and José Carlos Bouso
 
Life after Ayahuasca: A Qualitative Analysis of the Psychedelic Integration Experiences of 1630 Ayahuasca Drinkers from a Global Survey
by Tessa Cowley-Court, Richard Chenhall, Jerome Sarris, José Carlos Bouso, Luís Fernando Tófoli, Emérita Sátiro Opaleye, Violeta Schubert and Daniel Perkins
 
The Nose Knows: Aroma, but Not THC Mediates the Subjective Effects of Smoked and Vaporized Cannabis Flower
by Jeremy Plumb, Shaban Demirel, Jeremy L. Sackett, Ethan B. Russo and Adrianne R. Wilson-Poe
Views Article
A Multi-Level Analysis of Biological, Social, and Psychological Determinants of Substance Use Disorder and Co-Occurring Mental Health Outcomes
by Cecilia Ilaria Belfiore, Valeria Galofaro, Deborah Cotroneo, Alessia Lopis, Isabella Tringali, Valeria Denaro and Mirko Casu
Neurobiological Theories of Addiction: A Comprehensive Review
by Carmen Ferrer-Pérez, Sandra Montagud-Romero and María Carmen Blanco-Gandía
The Nose Knows: Aroma, but Not THC Mediates the Subjective Effects of Smoked and Vaporized Cannabis Flower
by Jeremy Plumb, Shaban Demirel, Jeremy L. Sackett, Ethan B. Russo and Adrianne R. Wilson-Poe
Life after Ayahuasca: A Qualitative Analysis of the Psychedelic Integration Experiences of 1630 Ayahuasca Drinkers from a Global Survey
by Tessa Cowley-Court, Richard Chenhall, Jerome Sarris, José Carlos Bouso, Luís Fernando Tófoli, Emérita Sátiro Opaleye, Violeta Schubert and Daniel Perkins
The Clinical Potential of Dimethyltryptamine: Breakthroughs into the Other Side of Mental Illness, Neurodegeneration, and Consciousness
by Frankie A. Colosimo, Philip Borsellino, Reese I. Krider, Raul E. Marquez and Thomas A. Vida
Unlocking the Potential of Meldonium: From Performance Enhancement to Therapeutic Insights
by Val Bellman
The Factors Affecting Substance Use and the Most Effective Mental Health Interventions in Adolescents and Young Adults
by Promethi Das Deep, Nitu Ghosh, Catherine Gaither and Md. Shiblur Rahaman
Does Cannabidiol (CBD) in Food Supplements Pose a Serious Health Risk? Consequences of the European Food Safety Authority (EFSA) Clock Stop Regarding Novel Food Authorisation
by Dirk W. Lachenmeier, Constanze Sproll and Stephan G. Walch
Transpersonal Ecodelia: Surveying Psychedelically Induced Biophilia
by Alexander Irvine, David Luke, Freya Harrild, Sam Gandy and Rosalind Watts
The Imperative of Regulation: The Co-Creation of a Medical and Non-Medical US Opioid Crisis
by Toine Pieters
Downloads Article
Neurobiological Theories of Addiction: A Comprehensive Review
by Carmen Ferrer-Pérez, Sandra Montagud-Romero and María Carmen Blanco-Gandía
A Multi-Level Analysis of Biological, Social, and Psychological Determinants of Substance Use Disorder and Co-Occurring Mental Health Outcomes
by Cecilia Ilaria Belfiore, Valeria Galofaro, Deborah Cotroneo, Alessia Lopis, Isabella Tringali, Valeria Denaro and Mirko Casu
The Nose Knows: Aroma, but Not THC Mediates the Subjective Effects of Smoked and Vaporized Cannabis Flower
by Jeremy Plumb, Shaban Demirel, Jeremy L. Sackett, Ethan B. Russo and Adrianne R. Wilson-Poe
Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression
by Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, Helena D. Aicher, Xaver Funk, Michiel van Elk, Marianna Graziosi, Prisca R. Bauer, Milan Scheidegger and David B. Yaden
Transpersonal Ecodelia: Surveying Psychedelically Induced Biophilia
by Alexander Irvine, David Luke, Freya Harrild, Sam Gandy and Rosalind Watts
Life after Ayahuasca: A Qualitative Analysis of the Psychedelic Integration Experiences of 1630 Ayahuasca Drinkers from a Global Survey
by Tessa Cowley-Court, Richard Chenhall, Jerome Sarris, José Carlos Bouso, Luís Fernando Tófoli, Emérita Sátiro Opaleye, Violeta Schubert and Daniel Perkins
Does Cannabidiol (CBD) in Food Supplements Pose a Serious Health Risk? Consequences of the European Food Safety Authority (EFSA) Clock Stop Regarding Novel Food Authorisation
by Dirk W. Lachenmeier, Constanze Sproll and Stephan G. Walch
The Clinical Potential of Dimethyltryptamine: Breakthroughs into the Other Side of Mental Illness, Neurodegeneration, and Consciousness
by Frankie A. Colosimo, Philip Borsellino, Reese I. Krider, Raul E. Marquez and Thomas A. Vida
New Psychoactive Substances: Health and Legal Challenges
by Inês C. Santos, Daniela Maia, Ricardo Jorge Dinis-Oliveira and Daniel José Barbosa
The Imperative of Regulation: The Co-Creation of a Medical and Non-Medical US Opioid Crisis
by Toine Pieters
Back to TopTop